AUROBINDO PHARMA
Back to All Ratios
|
AUROBINDO PHARMA Last 5 Year Core EBITDA Growth History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Core EBITDA Growth(%) | -14.83 | -17.62 | 13.02 | 23.10 | 6.03 |
What is the latest Core EBITDA Growth ratio of AUROBINDO PHARMA ?
Year | Core EBITDA Growth |
---|---|
Mar2023 | -14.83 |
Mar2022 | -17.62 |
Mar2021 | 13.02 |
Mar2020 | 23.10 |
Mar2019 | 6.03 |
How is Core EBITDA Growth of AUROBINDO PHARMA Trending?
Years | Core EBITDA Growth | % Change | |
---|---|---|---|
Mar2023 | -14.83 | Negative | |
Mar2022 | -17.62 | Negative | |
Mar2021 | 13.02 | -43.64 | |
Mar2020 | 23.1 | 283.08 | |
Mar2019 | 6.03 | - |
Other Financial Ratios of AUROBINDO PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Core EBITDA Growth ratio of peers of AUROBINDO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AUROBINDO PHARMA | ₹65,899.1 Cr | -2.4% | -1.1% | 88.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹363,535.0 Cr | 0.9% | -6.6% | 58.8% | Stock Analytics | |
CIPLA | ₹112,058.0 Cr | -1% | -5.6% | 54.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,414.0 Cr | 0.9% | 2.2% | 27.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,845.0 Cr | -2.2% | 6.2% | 21.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,676.3 Cr | 2.8% | -0.6% | 96.2% | Stock Analytics |
AUROBINDO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AUROBINDO PHARMA | -2.4% |
-1.1% |
88.7% |
SENSEX | -1.6% |
-0.5% |
19.8% |
You may also like the below Video Courses